Brief: Laurus Labs Says Usfda completed Inspection Of Facility at Andhra Pradesh
10/02/2023 11:15
Feb 10 (Reuters) - Laurus Labs Ltd LAUL.NS :
* USFDA COMPLETED INSPECTION OF FORMULATIONS MANUFACTURING FACILITY UNIT–2,
APSEZ, ANDHRA PRADESH
* BEEN ISSUED A FORM 483 WITH TWO OBSERVATIONS BY USFDA
* OBSERVATIONS ARE PROCEDURAL IN NATURE
* COMPANY WILL ADDRESS OBSERVATIONS WITHIN STIPULATED TIMELINES
Source text for Eikon: ID:nBSE7VGNSs
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig